Breaking News Instant updates and real-time market news.

JD

JD.com

$24.16

0.12 (0.50%)

, HIIQ

Health Insurance Innovations

$39.60

-6.55 (-14.19%)

07:30
11/06/18
11/06
07:30
11/06/18
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Monday in JD.com (JD), Health Insurance Innovations (HIIQ), TransUnion (TRU), and Flowers Foods (FLO).

JD

JD.com

$24.16

0.12 (0.50%)

HIIQ

Health Insurance Innovations

$39.60

-6.55 (-14.19%)

TRU

TransUnion

$66.59

-1.08 (-1.60%)

FLO

Flowers Foods

$18.85

0.08 (0.43%)

  • 08

    Nov

  • 12

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

JD JD.com
$24.16

0.12 (0.50%)

10/29/18
10/29/18
DOWNGRADE

Sector Weight
KeyBanc downgrades JD.com to Sector Weight on smartphone, appliance exposure
As previously reported, KeyBanc analyst Hans Chung downgraded JD.com to Sector Weight from Overweight, citing his view that ongoing weakness in the smartphone and home appliance markets could make JD more vulnerable than peers given its large exposure to those two end markets. Chung, who sees potential downside risk to consensus revenue growth in 2019, is expecting in-line to lower Q3 results and Q4 guidance from JD, he added.
10/22/18
BNCH
10/22/18
NO CHANGE
Target $36
BNCH
Buy
JD.com price target lowered to $36 from $43 at Benchmark
Benchmark analyst Fawne Jiang expects JD.com's near-term growth outlook to face some challenges from the macro headwinds that are industry-wide and thinks JD's margins could face increasing pressure from aggressive investments in R&D, logistics and new business initiatives. She lowered her price target on JD.com shares to $36 from $43 ahead of the company's Q3 earnings report, due in early to mid November, but maintains a Buy rating on the shares, given that she sees it continuing to benefit from secular consumption upgrade trends.
10/29/18
KEYB
10/29/18
DOWNGRADE
KEYB
Sector Weight
JD.com downgraded to Sector Weight from Overweight at KeyBanc
10/12/18
UBSW
10/12/18
NO CHANGE
Target $28
UBSW
Buy
JD.com price target lowered to $28 from $38 at UBS
UBS analyst Jerry Liu lowered his price target on JD.com to $28 from $38 as he believes the weakness in consumer demand in July was an early warning of issues that will likely persist. Those problems consist of labor market and wage growth softness, tightening of consumer lending, lower investment income, and tougher competition. Liu maintains his Buy rating on JD.com as the market may have already priced in his estimate revisions.
HIIQ Health Insurance Innovations
$39.60

-6.55 (-14.19%)

10/30/18
CHLM
10/30/18
NO CHANGE
Target $65
CHLM
Buy
Health Insurance Innovations price target raised to $65 from $58 at Craig-Hallum
Craig-Hallum analyst George Sutton raised his price target for Health Insurance Innovations to $65 from $58, citing the outlook for a strong Q4, 2019 benefiting materially from ASC606, and legal accrual suggestive of a favorable outcome. The analyst reiterates a Buy rating on the shares.
10/30/18
LSCM
10/30/18
NO CHANGE
Target $75
LSCM
Buy
Health Insurance Innovations price target raised to $75 from $51 at Lake Street
Lake Street analyst Mark Argento raised his price target for Health Insurance Innovations to $75 from $51 and reiterates a Buy rating on the shares following last night's Q3 results. The stock in late morning trading is up 96c to $45.96. The company reported "impressive" Q3 results and increased fiscal 2018 guidance by the amount of the Q3 beat, Argento tells investors in a post-earnings research note. He believes Health Insurance Innovations has "plenty of positives to look forward to" in Q4 and 2019, noting that extended duration short-term medical plans are in high demand. The company "is set to tackle a large and expanding addressable market," says Argento.
09/27/18
RILY
09/27/18
NO CHANGE
Target $60
RILY
Buy
Health Insurance Innovations price target raised to $60 from $56 at B. Riley FBR
B. Riley FBR analyst Randy Binner raised his price target for Health Insurance Innovations to $60 after hosting investor meetings with management. The company's revenue opportunities "are numerous" against a backdrop of continued mainstreaming of short-term and limited-benefit health plans that it distributes, Binner tells investors in a research note. He keeps a Buy rating on the shares.
10/29/18
FANA
10/29/18
UPGRADE
Target $65
FANA
Strong Buy
Health Insurance upgraded to Strong Buy from Outperform at First Analysis
First Analysis analyst Frank Sparacino upgraded Health Insurance Innovations to Strong Buy with an unchanged price target of $65. Federal regulatory guidance and a proposed rule released last week may provide "further tailwinds" for the company as early as 2020, Sparacino tells investors in a research note. Further, the analyst sees the extension of short-term, limited duration insurance policy durations from three months to 12 months with automatic renewal up to 36 months and the zeroing out of the individual mandate tax penalty as having a positive impact on Health Insurance Innovations in the short-term. Sparacino says the recent pullback in shares of Health Insurance Innovations makes the valuation "particularly compelling."
TRU TransUnion
$66.59

-1.08 (-1.60%)

10/24/18
BARD
10/24/18
NO CHANGE
Target $81
BARD
Outperform
TransUnion weakness a buying opportunity, says Baird
Baird analyst Jeffrey Meuler said he likes TransUnion shares a lot following their recent pullback. He said organic growth remains strong and broad-based, and the Q3 underlying margin performance was very strong. Meuler reiterated his Outperform rating and $81 price target on TransUnion shares.
10/23/18
BOFA
10/23/18
INITIATION
Target $84
BOFA
Buy
TransUnion reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Gary Bisbee reinstated coverage on TransUnion with a Buy and $84 price target saying he expects broad-based product momentum to continue. The analyst expects above average market-growth and to use the recent pullback as a buying opportunity. Bisbee named TransUnion a best idea in the Business and Information Services sector.
10/24/18
ATLE
10/24/18
UPGRADE
ATLE
Overweight
TransUnion upgraded to Overweight from Neutral at Atlantic Equities
10/24/18
10/24/18
UPGRADE
Target $82

Overweight
TransUnion upgraded to Overweight following pullback at Atlantic Equities
As previously reported, Atlantic Equities analyst Kunaal Malde upgraded TransUnion to Overweight from Neutral, noting that the stock has fallen 15% from its highs despite no real change to the company's outlook. The company's issues with certain clients, particularly in healthcare, that lead to a moderation in organic growth look transitory, Malde said. Noting that credit remains healthy, the analyst said he continues to estimate mid-teens EPS growth over the medium term. Malde keeps an $82 price target on TransUnion shares.
FLO Flowers Foods
$18.85

0.08 (0.43%)

08/06/18
08/06/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Equal Weight from Overweight at Barclays with analyst Blayne Curtis saying he believes upside in the shares will be challenging until the company's margins bottom. 2. Immune Pharmaceuticals (IMNP) downgraded to Hold from Buy at Maxim with analyst Jason McCarthy citing the company's delisting from Nasdaq and evaluation of strategic options as it seeks to resolve its financing overhang. 3. Flowers Foods (FLO) downgraded to Equal Weight from Overweight at Consumer Edge. 4. CommScope (COMM) downgraded to Hold from Buy at Jefferies with analyst George Notter saying after "further reflection" from the earnings call and conversations with industry contacts, he believes CommScope's Mobility division performance will not improve this year or next. 5. Acadia (ACAD) downgraded to Neutral from Overweight at Piper Jaffray with analyst Danielle Brill saying the recent negative headlines related to potential Nuplazid safety issues will continue to weigh on sales and the shares for the foreseeable future. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/06/18
CEDG
08/06/18
DOWNGRADE
CEDG
Equal Weight
Flowers Foods downgraded to Equal Weight from Overweight at Consumer Edge
07/09/18
07/09/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Hold from Buy at Jefferies with analyst Kevin Grundy saying slowing market growth, volatility in emerging markets, U.S. retail difficulties, the stronger U.S. dollar and "pricing challenges" should drive estimates lower. 2. SeaWorld (SEAS) and Six Flags (SIX) were downgraded to Market Perform from Outperform at Wells Fargo. 3. Walgreens Boots Alliance (WBA) downgraded to Neutral from Buy at Citi with analyst Ralph Giacobbe saying he finds it difficult to argue for "meaningful multiple expansion" given headwinds from industry pressures and a dynamic and changing backdrop. 4. Flowers Foods (FLO) downgraded to Hold from Buy at Vertical Group. 5. Wayfair (W) downgraded to Market Perform from Outperform with the firm citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/09/18
VERF
07/09/18
DOWNGRADE
VERF
Hold
Flowers Foods downgraded to Hold from Buy at Vertical Group

TODAY'S FREE FLY STORIES

MOTS

Motus GI Holdings

$4.49

0.19 (4.42%)

08:11
02/19/19
02/19
08:11
02/19/19
08:11
Hot Stocks
Motus GI Holdings announces publication of Pure-Vu system clinical study data »

Motus GI Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBC

Wabco

$116.78

0.19 (0.16%)

08:10
02/19/19
02/19
08:10
02/19/19
08:10
Recommendations
Wabco analyst commentary  »

Wabco estimates cut at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQV

Iqvia

$141.79

0.73 (0.52%)

08:09
02/19/19
02/19
08:09
02/19/19
08:09
Recommendations
Iqvia analyst commentary  »

Iqvia price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHH

Choice Hotels

$80.53

-1.47 (-1.79%)

08:09
02/19/19
02/19
08:09
02/19/19
08:09
Hot Stocks
Choice Hotels announces agreement with ServiceStar Hospitality »

Choice Hotels…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLDN

Willdan Group

$37.04

1.04 (2.89%)

08:09
02/19/19
02/19
08:09
02/19/19
08:09
Hot Stocks
Willdan Group awarded $7.5M project for plant upgrades in NY »

Willdan Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

BCLI

BrainStorm

$4.00

0.12 (3.09%)

08:09
02/19/19
02/19
08:09
02/19/19
08:09
Hot Stocks
BrainStorm 'committed' to advancing Phase 3 ALS trial towards BLA submission »

BrainStorm Cell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPIC

iPic Entertainment

$5.36

0.07 (1.32%)

08:08
02/19/19
02/19
08:08
02/19/19
08:08
Hot Stocks
iPic Entertainment appoints Carla D'Alessandro as Chief Marketing Officer »

IPIC Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPLK

Splunk

$136.16

1.57 (1.17%)

, TWLO

Twilio

$106.82

-0.445 (-0.41%)

08:07
02/19/19
02/19
08:07
02/19/19
08:07
Hot Stocks
Splunk names Carrie Palin CMO »

Splunk (SPLK) announced…

SPLK

Splunk

$136.16

1.57 (1.17%)

TWLO

Twilio

$106.82

-0.445 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 06

    Mar

  • 18

    Mar

EGHT

8x8, Inc.

$19.82

0.025 (0.13%)

08:07
02/19/19
02/19
08:07
02/19/19
08:07
Conference/Events
8x8, Inc. management to meet with Stephens »

Group luncheon with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 25

    Feb

  • 14

    Mar

  • 18

    Mar

  • 21

    Mar

TROV

Trovagene

$0.55

-0.0199 (-3.49%)

08:07
02/19/19
02/19
08:07
02/19/19
08:07
Hot Stocks
Trovagene announces 1 for 6 reverse stock split »

Trovagene announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$94.92

0.52 (0.55%)

, MA

MasterCard

$222.11

2.39 (1.09%)

08:07
02/19/19
02/19
08:07
02/19/19
08:07
Recommendations
PayPal, MasterCard analyst commentary  »

PayPal price target…

PYPL

PayPal

$94.92

0.52 (0.55%)

MA

MasterCard

$222.11

2.39 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 25

    Feb

  • 19

    Mar

NWL

Newell Brands

$17.15

-4.55 (-20.97%)

08:07
02/19/19
02/19
08:07
02/19/19
08:07
Recommendations
Newell Brands analyst commentary  »

Newell Brands price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

FELE

Franklin Electric

$50.88

1.71 (3.48%)

08:06
02/19/19
02/19
08:06
02/19/19
08:06
Earnings
Franklin Electric sees FY19 EPS before restructuring $2.37-$2.47 

Consensus is $2.40.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

MAGS

Magal Security

$5.31

(0.00%)

08:06
02/19/19
02/19
08:06
02/19/19
08:06
Hot Stocks
Magal Security awarded $4.2M in contracts by Israeli Ministry of Defense »

Magal Security Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAWW

Atlas Air

$54.41

0.09 (0.17%)

08:06
02/19/19
02/19
08:06
02/19/19
08:06
Earnings
Atlas Air reports Q4 adj. EPS $3.12, consensus $2.94 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

NVUS

Novus Therapeutics

$4.24

(0.00%)

08:06
02/19/19
02/19
08:06
02/19/19
08:06
Hot Stocks
Novus Therapeutics doses first patients in OP0201 Phase 2a trial »

Novus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

$115.89

3.4 (3.02%)

08:06
02/19/19
02/19
08:06
02/19/19
08:06
Upgrade
PepsiCo rating change  »

PepsiCo upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 18

    May

FELE

Franklin Electric

$50.88

1.71 (3.48%)

08:06
02/19/19
02/19
08:06
02/19/19
08:06
Earnings
Franklin Electric reports Q4 EPS 51c, consensus 49c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

CATB

Catabasis Pharmaceuticals

$4.27

-0.15 (-3.39%)

08:06
02/19/19
02/19
08:06
02/19/19
08:06
Hot Stocks
Catabasis Pharmaceuticals presents data from MoveDMD trial of edasalonexent »

Catabasis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHW

Sherwin-Williams

$439.24

7.53 (1.74%)

08:05
02/19/19
02/19
08:05
02/19/19
08:05
Hot Stocks
Sherwin-Williams names David Sewell as COO, effective March 1 »

The Sherwin-Williams…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

RWLK

ReWalk Robotics

$0.32

0.0204 (6.78%)

08:05
02/19/19
02/19
08:05
02/19/19
08:05
Hot Stocks
ReWalk Robotics submits 510k application to FDA for ReStore »

ReWalk Robotics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLO

Flowers Foods

$20.73

-0.01 (-0.05%)

08:04
02/19/19
02/19
08:04
02/19/19
08:04
Hot Stocks
Flowers Foods CEO Allen Shiver to retire, Ryals McMullian to succeed »

Flowers Foods announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLIR

Flir Systems

$52.44

0.93 (1.81%)

08:03
02/19/19
02/19
08:03
02/19/19
08:03
Hot Stocks
Flir Systems announces departure of General Counsel Todd DuChene »

FLIR Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

AMCN

AirMedia

$0.47

-0.0011 (-0.23%)

08:03
02/19/19
02/19
08:03
02/19/19
08:03
Hot Stocks
AirMedia subsidiary files lawsuit to resolve disputes in China »

AirMedia Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

08:02
02/19/19
02/19
08:02
02/19/19
08:02
Downgrade
Lululemon rating change  »

Lululemon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.